clinical trial · NCT06619665
A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)
Merck Sharp & Dohme LLC·phase1·completed·n = 18
HealthyNarcolepsyMK-6552MK-6552 placeboModafinilModafinil placebo
brief summary
This study examined the safety of the drug MK-6552 and if people tolerated it. It also studied whether MK-6552 works better than placebo for staying awake in sleep deprived healthy participants.
started
Mar 19, 2024
primary completion
Jul 16, 2024
completion
Jul 16, 2024
last updated
Oct 1, 2024
official title
A Randomized, Double-blind, 3-Period Crossover Study to Assess the Effects of MK-6552 on Sleep Latency in Sleep Deprived Healthy Participants With Modafinil as a Positive Control
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol